Page last updated: 2024-11-04

vorinostat and Pneumonia

vorinostat has been researched along with Pneumonia in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Pneumonia: Infection of the lung often accompanied by inflammation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, Q1
Su, Z1
Song, S1
Χu, H1
Zhang, B1
Yi, L1
Tian, M1
Wang, H1

Other Studies

1 other study available for vorinostat and Pneumonia

ArticleYear
Histone deacetylase inhibitors suppress RSV infection and alleviate virus-induced airway inflammation.
    International journal of molecular medicine, 2016, Volume: 38, Issue:3

    Topics: Animals; Blotting, Western; Bronchi; Cell Line; Cell Line, Tumor; Cyclooxygenase 2; Cytokines; Epith

2016